Related Experiment Video
Updated: Aug 12, 2026
13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Human papillomavirus: emerging trends in detection and management
Jason D Wright1, Thomas J Herzog
1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, 4911 Barnes Hospital Plaza, Box 8064, St. Louis, MO 63110-1094, USA. wrightj@msnotes.wustl.edu
Current Women'S Health Reports
|August 2, 2002
Summary
Human Papillomavirus (HPV) DNA is found in over 99% of cervical cancer cases. This review covers current and emerging HPV detection methods for clinical practice.
Area of Science:
- Oncology
- Virology
- Public Health
Background:
- Cervical cancer remains a significant global health issue.
- Current screening relies on cervical cytology for early detection.
- Over 99% of cervical carcinomas are associated with Human Papillomavirus (HPV) DNA.
Purpose of the Study:
- To review existing Human Papillomavirus (HPV) detection methods.
- To explore emerging strategies for integrating HPV testing into clinical practice.
Main Methods:
- Review of current scientific literature on HPV detection techniques.
- Analysis of emerging diagnostic and screening strategies for HPV.
Main Results:
- Human Papillomavirus (HPV) is a primary cause of cervical cancer.
- Various molecular methods exist for HPV DNA detection.
- Emerging strategies focus on improving accessibility and efficiency of HPV testing.
Conclusions:
- HPV testing is a crucial tool for cervical cancer prevention and early detection.
- Implementation of HPV testing can enhance current screening protocols.
- Further research into novel HPV detection methods is warranted.
Related Concept Videos
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:26Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
01:28Herpes
Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
01:23Genital Herpes
Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
01:18Trichomoniasis
Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.